Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma-Reference-Cited by-同舟云学术

Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma

Published:2019-01-10 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Zhang Xingming,Yin Xiaoxue,Zhang Haoran,Sun Guangxi,Yang Yaojing,Chen Junru,Shu Kunpeng,Zhao Jinge,Zhao Peng,Chen Ni,Wang Jia,Shen Pengfei,Zeng Hao^ORCID

Funder

National Natural Science Foundation of China

Sichuan Province Science and Technology Support Program

Department of Science and Technology of Sichuan Province

1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5273-5.pdf

Reference32 articles.

1. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003;30(4):843–52.

2. Fyfe G, Fisher RI, Rosenberg SA, Sznol M, Parkinson DR, Louie AC. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol. 1995;13(3):688–96.

3. McDermott DF, Regan MM, Clark JI, Flaherty LE, Weiss GR, Logan TF, Kirkwood JM, Gordon MS, Sosman JA, Ernstoff MS, et al. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J Clin Oncol. 2005;23(1):133–41.

4. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili R, Bjarnason GA, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol. 2009;27(22):3584–90.

5. Raman R, Vaena D. Immunotherapy in metastatic renal cell carcinoma: a comprehensive review. Biomed Res Int. 2015;2015:367354.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reprogramming of Glycine max (Soybean) Proteome in Response to Spodoptera litura (Common Cutworm)-Infestation;Journal of Plant Growth Regulation;2024-02-05

2. Analysis of the immunological markers BTLA, TIM-3, and PD-L1 at the invasion front and tumor center in clear cell renal cell carcinoma;World Journal of Urology;2024-01-20

3. Effects of exercise, physical activity, and sports on physical fitness in adults with Down syndrome: A systematic review;AIMS Public Health;2024

4. Long non-coding RNA-mediated epigenetic response for abiotic stress tolerance in plants;Plant Physiology and Biochemistry;2024-01

5. TIM-3 transcriptomic landscape with clinical and immunomic correlates in cancer;American Journal of Cancer Research;2024